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$ummaary 
The proliferation of antigen-activated T cells is mediated by the T cell-derived growth factor, 
interleukin 2 (IL-2). The biochemical signaling cascades initiating IL-2-induced growth are 
dependent upon protein ryrosine kinase (FFK) activity. One IL-2-regulated FTK implicated in 
this cascade is the Src-family kinase, Fyn. Previous studies have described a physical association 
between Fyn and a potential downstream substrate, phosphatidylinositol  3-kinase (PI3-kinase) 
as well as the IL-2-dependent activation of PI3-kinase in T cells; however, the role of Fyn in 
IL-2-induced PI3-kinase activation remains unclear. In this report, we demonstrate that IL-2 
stimulation triggers tyrosine phosphorylation of the p85 subunit of PI3-kinase in the murine 
T cell line, CTLL-2. Lysates prepared from growth factor-deprived and IL-2-stimulated T cells 
reconstituted both the binding of CTLL-2 cell-derived Fyn to and the IL-2-inducible tyrosine 
phosphorylation of exogenously added recombinant p85. Furthermore,  overexpression of wild- 
type Fyn in these cells  enhanced  both the basal and IL-2-mediated activation  of  PD-kinase. Additional 
studies of the Fyn-PI3-kinase interaction demonstrated that the Src homology 3 (SH3) domain 
of Fyn constitutes a direct binding site for the p85 subunit of PI3-kinase. These results support 
the notion that Fyn may be directly involved  in the activation of the downstream signaling enzyme, 
PI3-kinase, in IL-2-stimulated T  cells. 
ntigenic stimulation of resting T cells initiates entry into 
the cell cycle (G0- to G~-phase transition) and the syn- 
thesis of both the IL-2 receptor (IL-2R) 1 and its cognate 
ligand, IL-2. IL-2R occupancy then triggers G1- to S-phase 
progression, and commits the cell to traverse the remainder 
of the cell cycle. Although the biological effects of IL-2 on 
immune cell function are well known, the intracellular bio- 
chemical mechanisms coupling IL-2R stimulation to IL-2-in- 
duced T  cell mitogenesis are poorly understood. 
The high-2f~nity IL-2R is minimally a heterotrimeric com- 
plex consisting of 55-kD (ol, p55), 70-kD (fl, p70), and 64- 
kD (% p64) polypeptide subunits (reviewed in 1). Although 
all three subunits  are required for high-affinity binding to 
ligand, the human p70 and p64 subunits comprise an inter- 
mediate af~nity receptor, and the p70-p64 heterodimer can 
confer mitogenic responsiveness to IL-2 (2, 3). The IL-2R 
p70 and p64 subunits are members of the cytokine receptor 
superfamily. Like other members of this family, the deduced 
1 Abbreviations used in this paler: GSH,  ghtathione;  GST, glutathione 
S-transferase; IL-2R,  IL-2  receptor;  PI3-kinase,  phosphatidylinositol 
3-kinase; PTK, protein tyrosine kinase; Ptyr, phosphotyrosine; SH, Src 
homology. 
amino acid sequences of the cytoplasmic domains of the IL- 
2R subunits predict no homology to protein kinase catalytic 
motifs, yet IL-2R occupancy elicits a rapid increase in the 
tyrosine phosphorylation of multiple intracellular proteins 
(4-6). The Src-family kinases, Lyn, Fyn, and Lck have been 
postulated to function as IL-2R-linked protein tyrosine ki- 
nase (FTK). All three are rapidly and transiently activated 
by IL-2K stimulation (7, 8). Moreover, both Fyn and Lck 
are physically  associated  with the IL-2K complex (8-10). These 
findings suggest that certain Src-fmnily  FFKs may serve  wholly 
or partially redundant functions in the transmission of the 
IL-2R-initiated mitogenic signal (8-12). However, the mo- 
lecular mechanisms that target these receptor-activated FTKs 
to downstream signal-transducing  molecules  remain enigmatic. 
Previous studies have shown that IL-2 stimulation of T 
cells results in the rapid FFK-dependent activation of phos- 
phatidylinositol 3-kinase (PI3-kinase) (13-15). In addition, 
PI3-kinase is coprecipitated with the IL-2R complex (15) and 
the Src-family kinase, Fyn (13). While the actual function 
of PI3-kinase is unknown, the enzyme appears to be a ubiq. 
uitous and essential component of PTK-initiated mitogenic 
response pathways (16). PI3-kinase is a heterodimer composed 
of an 85-kD regulatory subunit and a 110-kD  catalytic subunit 
(17, 18). Two potential molecular mechanisms for the cata- 
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cording to one modal, the Src homology 2 (SH2) domains 
of p85 bind to autophosphorylated growth factor receptors 
or their substrates. This interaction induces an allosteric al- 
teration that activates the 110-kD catalytic subunit. The al- 
ternative model predicts that tyrosine phosphorylation of p85 
itsdf increases  the catalytic activity of the 110-kD subunit. 
However, the PI3-kinase activation mechanism employed by 
the IL-2R is currently unknown. 
To more fully dissect the biochemical linkages among the 
IL-2R, the Src-family kinases,  and downstream signal-trans- 
ducing moieties, we have focused on the IL-2-induced acti- 
vation of PI3-kinase.  The studies described herein demon- 
strate that  the p85 subunit  of PI3-kinase is a direct target 
for an IL-2-inducible tyrosine kinase in intact T cells. In vitro 
studies demonstrated the binding  of T  cell-derived Fyn to 
a recombinant p85 fusion protein and the IL-2-indudble tyro- 
sine phosphoryhtion  of the recombinant p85. In addition, 
overexpression of wild-type Fyn in CTLL-2 cells enhanced 
both basal and IL-2-stimuhted  PI3-kinase activity.  Using 
recombinant fusion proteins, we observed that  the isolated 
Fyn SH3 domain could bind directly to the p85 subunit of 
PI3-kinase.  Taken together, these results define a direct coup- 
ling mechanism between IL-2R-mediated Pyn activation and 
the subsequent phosphorylation and activation of the down- 
stream  signaling  enzyme,  PI3-kinase. 
Materiah  and Methods 
Reagents.  The anti-p85 rabbit antiserum and the antiphospho- 
tyrosine (Ptyr) mAb, 4G10, were obtained from Upstate Biotech- 
nology, Inc. (Lake Phdd, NY). The rabbit anti-Fyn antiserum has 
been described previously (11). The IL-2 was a generous gift of 
Hoffmann-LaRoche, Inc. (Nutley, NJ). The anti-KT3  mAb (20) 
was obtained from G. Walter (University of California, San Diego, 
CA).  The pGEX-KG vector (21) was from J. Dixon (University 
of Michigan,  Ann Arbor,  MI), the pREP3 vector was from J. 
Tykocinski (Case Western Reserve University, Cleveland, OH [22]), 
and the routine p85 eDNA (17) was obtained from L. Williams 
(University  of California,  San Frandsco,  CA).  The fFt and kte 
cDNAs  were  generous  gifts  of R.  Perlmutter  (University  of 
Washington,  Seattle, WA). 
Plasraid Construction.  To construct  glutathione  S-transferase 
(GST)-Fyn  NH (amino  adds  1-85)  and GST-Fyn  sm (amino  adds 
84-141) expression vectors, the respective oligonucleotide pairs 5'- 
C GACAGGATCC  GCTAGATAC  CATC,  G GC'I~TGTG  CAA1Wr-3  ', 
5'-CGAGCAGCTGAAGCTTTGTCACTCCTGTCCCTCC-3', 
and  5  ' -  CGAC  AGGA3~  CTCTAGATAC  CATCM3TGACACTGTT- 
TGTGC,  CG-Y, 5  '- CGAGCAGCTGAAGCTTAACTGGAGC CA- 
CGTAAT-3' were used to prime PCRs. The amplification prod- 
ucts were digested with HindIII and XbaI and cloned into the 
pGEX-KG vector backbone digested with the same restriction en- 
zymes. All PCR-derived clones were sequenced to verify that no 
errors  were  introduce.  To  construct  the  GST-FYN  NH-sm-sm 
(amino adds 25-265).  The f~-containing  vector, pMTFR, was 
digested with SacI, and the resultingfFt  fragment (encoding amino 
adds 25-358) was ligated into SacI-dige,  sted pSP72 (Promega Corp., 
Madison, WI). The pSP72-Fyn construct was digested with EcoRV 
and XbaI and ligated into the Sinai- and XbaI-digested pGEX-KG 
vector. The fusion protein produced from this vector was insoluble. 
To truncate the fusion protein, the plasmid was digested with PMU 
(truncating  the protein at amino add 265) and HindlII (cutting 
in the pGEX-KG polylinker 3' to the insert). The DNA ends were 
rendered flush by treatment  with the Klenow fragment of Esche- 
richia coli DNA polymerase, and the fragments religated under di- 
lute conditions. The resulting plasmid was designated pGEX-KG- 
FYN  N"-sm-sm (amino acids 25-265). To construct the GST-Fyn  sm 
expression plasmid, a HinclI to PmlI fragment offyn (amino adds 
142-265) was excised from pMTRF and subdoned into EcoRV- 
digested pSP72, pSP72-Fyn  sm was then digested with BgllI and 
EcoRI and thefyn-containing  fragment was ligated into BamHI- 
and EcoRI-digested  pGEX-KG. 
To generate the GST-Ixk fusion protein expression vector, the 
kk-containing  vector, pMNC-LCK, was first digested with PstI 
to release an kk fragment encoding amino acids 5-295. The DNA 
fragment was ligated into PstI-digested pGEM3-Zf(-). To generate 
an inframe fusion with the GST coding sequences, the pGEM-Lck 
vector was digested with XbaI and HindIII and the resulting k/r 
fragment was subdoned into XbaI- and HindlII-digested  pGEX- 
KG. The fusion protein expressed from this vector was insoluble. 
Therefore, the vector was digested with NcoI (cuts within the/c/e 
coding sequence at amino add 232) and HindlII (cuts within the 
polylinker sequence, 3' to the k/e insertion). The vector-containing 
fragment was treated with the Klenow fragment of E. coli DNA 
polymerase, and the phsmid was religated under dilute conditions. 
To generate the GST-p85 expression phsmids,  the vector con- 
raining the p85 eDNA was digested with PstI. To construct GST- 
p85  ~Iss-n4, the p85 phsmid was digested to completion with PstI 
and the resulting fragment (encoding amino adds 158-724 of p85) 
was subcloned into pSP72. The resulting phsmid was digested with 
SalI and HindIII and the p85-containing  fragment  was ligeted 
into Sail- and HindIII-digested  pGEX-KG. To prepare the GST- 
p85  ~l-r~ expression vector, the p85 plasmid was partially digested 
with PstI. The fragment encoding fuR-length p85 was gel-purified 
and ligated into PstI-digested pSP72. This phsmid was digested 
with SalI and HindlII, and the p85-containing fiagment was ligated 
into SalI- and HindIII-digested  pGEX-KG. This insertion gener- 
ated an inframe insertion  with the GST coding sequence. 
To construct the epitope-tagged Fyn expression vector, pREP3- 
Fyn~'-KT3,  the 8-amino add KT3 epitope tag (TPPEPET)  was 
appended onto the 3' end of the full-length fyn coding sequence 
using  the polymerase chain  reaction.  The oligonudcotides,  5'- 
GAAT~ GAT_A_TCTAGA  ~  TGI3CTC~AATGT-  3 '  and 
5  'C  GATGCATC~CTCGAGTCATGT TTCIGGTTCTGGTGG - 
TGGTGTCAGGTIT1X2ACC~3'  wexe  used to prime the 
polymerase chain reaction. The resulting amplification product was 
digested with XhoI and Xbal and the fragment was ligated into 
NheI- and XhoI-digested  pREP3. 
Preparation of Fusion Proteins.  Fusion proteins were expressed 
in the E. coli strain DH5o~  transformod with the appropriate vectors. 
The cultures were induced with 0.2 mM isopropyl-~-v-thiogahcto- 
pyranoside and incubated for 2-3 h for production of GST-Fyn fu- 
sion proteins and 20 min for the preparation  of GST-p85 fusion 
proteins. The cells were resuspended in 0.01 M sodium phosphate, 
0.15 M NaC1, 10 mM EDT_A, (pH 7.4) 10 mM dithiothreitol,  1% 
Triton X-100, and 0.03% SDS containing  10/~g/ml leupeptin,  5 
/zg/ml pepstatin,  5/zg/ml aprotinin,  and 1 mM PMSF, and dis- 
rupted by sonication. The GST fusion proteins were purified using 
glutathione (GSH)-coupled agarose (Sigma Chemical Co., St. Louis, 
MO). 
Cell Culture.  The CTLL-2 cells were obtained from American 
Type Culture Collection (Rockvillg MD). The cell culture condi- 
tions, as well as the derivation of the CTLL.Ick- cell line, were 
described previously (11). Where indicated,  CTLL-2 cells were 
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lations by culturing in R.PMI 1640 medium supplemented with 
1% BSA, 2 mM r-glutamine, 50/~M 2-ME, and 10 mM Hepes 
(pH 7.2). 
Cell Transfictions.  Exponentially growing CTLL-2 cells (107 
cells/transfection) were mi~xl with DNA. The mixture was in- 
cubated at room temperature for 10 min and dectroporated at 475 
V, 600/~F in a 0.4-mM cuvette using an ECM 600 apparatus (BTX, 
In~, San Diego, CA). After dectroporation, the ceils  were incubated 
at room temperature for 15 min and diluted into culture medium. 
After 24 h, 400/~g/ml hygromycin B was added. Drug-resistant 
cells were doned by limiting dilution. To identify cells lines ex- 
pressing epitope-tagged Fyn, the tagged Fyn was immunoprecipi- 
tated with the KT3 monodonal antibody (20), and the precipi- 
tates were subjected to a kinase reaction as described below. The 
Fyn-KT3-expressing clones were identified by the presence of ~zp. 
labeled autophosphoryhted  Fyn. 
Immune Complex and Fusion-Protein Kinase Reactions.  Immune 
complexes or fusion protein precipitates were washed with im- 
mune complex kinase  buffer (50 raM Pipes [pH 7.0], 0.02% Triton 
X-100, 10 mM NaCI, 10 mM MgCh, 2 mM MnCh, and 1 mM 
Na3VO4). The immune complexes were subjected to kinase reac- 
tions by addition of 10 or 20/~Ci 3~-[3zp]ATP (50 Ci/mmol) and, 
where indicated, 5/~g acid-denatured enolase (11). Proteins were 
fractionated by SDS-PAGE, and transferred to Immobilon P as pre- 
viously described (11). Radiohbeled proteins were visualized  by au- 
toradiography,  and protein-bound  radioactivity  was quantitated  with 
an imaging system (AMBIS Systems Inc., San Diego, CA). 
Phospkorflation of  p85 in Intact Cells.  ID2-deprived  CTLL-2  cells 
(2  x  107 cells/sample) were washed once with PBS (0.01 M so- 
dium phosphate, 0.15 M NaC1 [pH 7.4]) containing I mg/ml glu- 
cose and resuspended in I ml of the same buffer. After warming 
to 37~  the cells were either pretreated or not for 2 rain with 
30/~M vanadyl  hydroperoxide  (pervanadate; [23, 24]). Samples  were 
then stimulated with medium or ID2, and the cells were lysed in 
PI3-kinase lysis  buffer (20 mM "li'is-HC1, 137 mM NaCI, 40 mM 
~-glycerophosphate, 1 mM CaCh, 1 mM MgCh, 10% glycerol 
[pH 7.4]) containing 1% Triton X-100, 1 mM Na3VO4, 10/~g/ml 
leupeptin, 5/~g/rnl pepstatin, 5/~g/ml aprotinin, and 1 mM PMSF. 
Cell lysates  were immunoprecipitated anti-p85 antiserum. The im- 
mune comple~s were washed  with PI3-kinase  lysis  buffer containing 
1.0% Triton X-100, 1.0% deoxycholate, 0.1% SDS, and 1 mM 
NasVO4, and were fractionated by SDS-PAGE. The proteins were 
transferred to an Immobilon-P membrane (Millipore Corp., Bed- 
ford, MA), and the membrane was probed with an anti-Ptyr mAb 
as previously  described  (11). The membrane was then stripped with 
7 M guanidine hydrochloride,  10 mM dithiothreitol, and immuno- 
blotted with anti-p85 antiserum, followed by a 1:10,000 dilution 
of a horseradish  peroaidase-protein  A conjugate (Amersham  Corp., 
Arington Heights, IL). Immune complexes  were detected with the 
enhanced chemiluminescent detection reagent (ECL; Amersham 
Corp.). 
F2m-p85 Binding Assays.  Purified  GST-Fyn  fusion proteins (in 
0.2 M sodium bicarbonate) were coupled to cyanogen bromide- 
activated Sepharose (Sigma Chemical Co.) at a concentration of 
0.2/~mol of fusion protein/ml of resin. For each binding reaction, 
15/~1 of  packed  beads were mixed with 20/~g of  full-length, soluble 
GST-p85  ~1-7u (amino acids 1-724) in  1 mi of PI3-kinase lysis 
buffer containing 1 mM dithiothreitol, 0.5% Brij 96, 10 rag/m1 
BSA, and 2/~g/rnl of soluble GST. The soluble GST served as a 
competitor for a weak background GST-GST-p85 interaction. The 
samples were rotated for I h at 4~  washed with lysis  buffer, and 
fractionated by SDS-PAGE (10% gel). The gel was transferred to 
Immobilon P and the membrane was immunoblotted with anti- 
p85 antiserum, with the exception that the blotting solution was 
precleared of GST-reactive antibodies by tandem 2-h incubations 
with 500/~g of  GST bound to GSH-Sepharose, followed  by a single 
incubation with GSH-Sepharose only. Finally, 500/~g of SDS- 
denatured GST (prepared by heating for 10 rain at 100~  in 0.1% 
SDS) were added to the blotting sohtion. 
GST-p85 Binding and Kinase Assays.  Growth factor-deprived 
CTLL-2  cells  were stimuhted for the indicated  times with 200 U/ml 
IL-2, The cells  were lysed  in PI3-kinase  lysis  buffer containing  0.25% 
Triton X-100, I mM NasVO4, 10/~g/ml lenpeptin, 5/~g/ml pep- 
statin, 5/zg/ml aprotinin, and 1 mM PMSF. Cell lysates were in- 
cubated with 10/~g GSH-agarose-bound  GST-p85 ~1~7~ for 1 h, 
and the resulting precipitates were subjected to kinase reactions 
as described above. Phosphoamino acid analyses were performed 
on the szP-labeled, membrane-bound GST-p85 bands as previously 
described (25). 
A paralld set of GST-p85-based kinase reactions was analyzed 
for radiohbeled Fyn. After the kinase reaction, the samples were 
adjusted to 1% SDS and heated for 20 min at 100~  After heating, 
the samples were diluted with PI3-kinase lysis buffer containing 
1% Triton X-100 to a final SDS concentration of 0.1%. Insoluble 
material was removed  by centrifugation, and the supernatant was 
immunoprecipitated  with anti-Fyn antiserum. The immunoprecipi- 
tares were fractionated by SDS-PAGE. The gel proteins were trans- 
ferred to Immobilon P and the membrane was exposed to film. 
PI3 Kinase Assays.  Wild-type CTLL-2  or lck-deficient  CTLL-2 
(CTLL.Ick-)  cells were deprived of ID2 for 12 b and then re- 
stimulated for 15 rain with 200 U/ml recombinant IL-2. At the 
end of the reaction, the cells were lysed in PI3-kinase lysis buffer 
containing  0.25%  Triton  X-100,  1  mM  NasVO4, 10  /~g/ml 
leupeptin, 5/~g/ml pepstatin, 5/~g/ml aprotinin, and I mM PMSF. 
Cleared lysates  were incubated with either anti-Ptyr mAb-coupled 
Sepharose (4), GSH-agarose-bound  GST-Fyn  fusion  protein, or GST- 
Fyn--coupled Sepharose. The predpitates were washed with PI3- 
kinase lysis  buffer containing 0.1% Triton X-100, 1 mM Na3VO4, 
and 0.2 mM adenosine,  and with 10 mM Tris-HCl, 100 mM NaCI 
(pH 7.6) containing 1 ram NasVO4, and 0.2 mM adenosine. PI3- 
kinase reactions were performed as previously described (13). 
Results 
IL-2 Induces tke Tyrosine Pkospkorylation of p85.  Stimula- 
tion of T cells with IL-2 results in an increase in PI3-kinase 
activity recoverable  in anti-Ptyr mAb immunoprecipitates 
(13-15).  To determine if this increase is due, in part, to the 
tyrosine phosphorylation of a component of PI3-kinase it- 
self,  we  stimulated  IL-2-deprived  CTLL-2  cells  with  a 
saturating concentration of IL-2 in the presence  or absence 
ofpervanadate, a potent tyrosine phosphatase inhibitor in intact 
T cells (23, 24). Subsequently, detergent-sohble proteins were 
immunoprecipitated with anti-p85 antiserum, and the im- 
munoprecipitates were resolved by SDS-PAGE and immuno- 
blotted with an anti-Ptyr mAb. Stimulation of nonpretreated 
CTLL-2 cells with IL-2 for 15 min elicited a readily detect- 
able increase in the tyrosine phosphorylation of p85 (Fig.  1 
A). In pervanadate-pretreated  cells, p85 exhibited a basal level 
of tyrosine phosphorylation that was comparable to that in- 
duced by IL-2 in nonpretreated cells (Fig. 1 A, compare lanes 
2 and 3). Stimulation of the pervanadate-pretreated  cells with 
IL-2 resulted in a marked increase in the tyrosine phosphory- 
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of p85 has been reproducibly observed in at least three sepa- 
rate experiments. Fig.  1 C  demonstrates that neither IL-2 
nor pervanadate treatment affected the recovery of p85 in the 
immunoprecipitates. 
To determine whether enhanced levels of p85 phosphory- 
lation were correlated with increased  PI3-kinase activity, 
CTLL-2 ceUs were treated with pervanadate and IL-2 as de- 
scribed for Hg. 1 A, and anti-Ptyr antibody-bound PI3-kinase 
activities  were determined (Fig.  1 B). The results indicate 
that increased levels of p85 phosphorylation were accompa- 
nied by the increased recovery of PI3-kinase activities in the 
anti-Ptyr mAb precipitates. Although pervanadate increased 
the basal tyrosine phosphorylation of p85 (as determined by 
anti-Ptyr blotting) to levels similar to that observed with IL-2 
alone., it dramatically enhanced the PI3-kinase activity bound 
to anti-Ptyr immunoprecipitates.  This discrepancy may 
the enhanced tyrosine phosphorylation of the p110 subunit 
(Fig.  1  A),  other  posttranslational  modifications of the 
p85-p110 heterodimer, or other protdn-protdn associations 
induced by the pervanadate treatment. 
GST-p85 Binds  an 1L-2-in~cible Tymsine  Kinase  Activi~  To 
examine the molecular machinery that couples the IL-2R to 
PI3-kinase,  we attempted to recapitulate the IL-2-induced 
phosphorylation of p85  in vitro.  Growth factor-deprived 
CTLL-2 cells were restimulated for various times with IL-2, 
and cell lysates were incubated with a GST fusion protein 
containing amino acids 158-724 of p85 (GST-p85  AA158-724) 
bound to GSH-coupled agarose beads. The washed precipi- 
tates were incubated with 'y-[3Zp]ATP  in kinase buffer and 
were resolved by SDS-PAGE. IL-2 stimuhtion induced a rapid 
increase in protein kinase activity precipitated by the GST- 
p85  ^^tSs-~24 substrate  (Fig.  2 A,  right). In contrast,  GST 
alone (Fig. 2 A, left) precipitated <5% of the kinase activity 
precipitated by GST-p85  ^^15s-Tu. In addition, this very low- 
level kinase activity was not IL-2 inducible. Repeat experi- 
ments indicated that IL-2 stimulated a two- to fourfold increase 
in GST-p85 ~1~-724 phosphorylation. To determine whether 
the protein kinase activity phosphorylated GST-p85  ~1s~-724 
on tyrosine or serine/threonine  residues, phosphoamino acid 
analysis was performed on the GST-p85  ~1ss-72~ band. The 
majority of the IL-2-inducible phosphorylation occurred on 
tyrosine residues, although a low basal level of serine phos- 
phorylation was also evident (Fig.  2 B). 
GST-p85 Binds IL.2-activated Fyn.  To identify the PTK 
associated  with  the  GST-p85  fusion protein,  the kinase- 
bound GST-p85  ~15s-Tz4 precipitates  were incubated with 
"y-[3zp]ATP, the  protein  comple~s  were  disrupted  with 
SDS, and the denatured proteins were rdmmunoprecipitated 
with a Fyn-spedfic rabbit antiserum. The results in Fig.  2 
C demonstrated that GST alone did not precipitate Fyn ki- 
nase activity.  However,  the GST-p85 precipitates  contained 
3zp-labeled Fyn. Additionally, Ix:k, the only other Src-family 
kinase expressed in these cells (11), could not be shown to 
specifically bind to the GST-p85  ^^tss-~z4 fusion protein. 
If Fyn were responsible for the IL-2-induced phosphory- 
lation of GST-p85, then IL-2-induced Fyn activation should 
coincide with the IL-2-dependent tyrosine phosphoryhtion 
of p85. To determine the time course of ~  activation in 
~ponse to IL-2, epitope-tagged r-yn (F~-KT3) was ~pressd 
in CTLL-2 cells. The addition of the KT3 epitope permitted 
selective recovery of the transfected Fyn with the KT3 mAb 
(20). Relative to immunoprecipitates  prepaz~ with our poly- 
donal rabbit anti-F~ antisera, the KT3 immunoprecipitates 
contained  significantly  lower  levels of  nonspecitic  con- 
taminating proteins, induding immunoglobnlin  heavy chains 
(our unpublished observations). Growth factor-deprived, l~n- 
KT3--expressing cells were rcstimulated with IL-2 for the in- 
dicated times. Call lysates were predpitated with the KT3 
mAb, and the precipitates  were incubated in kinase buffer 
containing 3~-[3ZP]ATP (Fig. 3). l~n activation was detected 
within 5 min of IL-2 stimulation, which was consistent with 
the rapid kinetics of p85 phosphorylation observed in the 
in vitro kinase assay. The KT3 mAb precipitated very low 
levels of nonspedfic enolase-phosphorylating activity from 
either untransfected or empty vector-transf~zgl CTLL2 cells 
(data not shown). Collectively, these results demonstrate that 
Figure  1.  IL-2-induced  tyrosine  phosphorylation  of p85 in intact  cells. 
Two parallel sets of IL-2-deprived  CTLL-2  cells  were  tither pretreated  or 
not with 30 ~M pervanadate  (PerVO4)  for 2 rain at 37~  and the ceils 
were then stimulated  for 15 min with medium  only or with IL-2. (,4) 
The  anti-p85  antibody  immunoprecipitates  were  fractionated  by SDS-PAGE 
(10% gel). The gd proteins  were transferred to Immobilon  P, and the 
membrane  was immunoblotted  with an anti-Ptyr  mAb. (/3) Lysat~  from 
the second  set of cells (stimulated  as described  in A) were precipitated 
with an anti-Ptyr  mAb,  and bound  PI3-kinase  activities  were  assayed.  (C) 
The membrane  shown  in A was stripped  and reprobed  with an anti-p85 
antiserum. The e~periment  shown  is representative  of three  independent 
trials. 
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pressing CTLL-2 cells were restimulated with IL-2 for the indicated times. 
Cell lysates were immunoprecipitated with the KT3 mAb, and the im- 
mune comple~tes were incubated with "y-[32P]ATP. Acid-denatured eno- 
lase was added as an exogenous substrate.  The reactions were terminated 
with Laemmli sample buffer and fractionated by SDS-PAGE (10%  gel). 
Proteins were trausk,  rred to Immobilon P and radiohbeled proteins were 
detected by autoradiography. Quantitation of enolase trans-phosphoryhtion 
is indicated bdow the pand. Data represent the net counts detected in 
a 30-min data acquisition period. The migration positions of both Fyn 
and enolase are indicated. 
Figure  2.  Association  of an ID2-activated PTK with recombinant p85. 
(A) Growth factor-deprived CTLb2 cells were stimulated with IL-2  for 
the indicated times and lysed. Dctergent-sohble proteins were concomi- 
tantly incubated with  either GSH-agarose-bound (;ST  (/eft) or  GST- 
p85  AA1sS-Tu (right), and the precipitates were incubated with ~/-[32p]ATP 
as described in Materials and Methods. Precipitated proteins were frac- 
tionated by SDS-PAGE (10% gel), trans~rred to Immobilon P, and radio- 
labeled species were detected by autoradiograpby. The incorporated radio- 
activity was quantitated with an imaging system (AMBIS Systems, Inc.). 
Data shown below A represent the number of counts detected in a 22-h 
data acquisition period (indicated as Net counts). Both phosphoryhted GST 
and GST-p85  AAlss-724  were autoradiographed for equivalent  time periods. 
The low level  of GST phosphoryhtion could not be reproduced photographi- 
cally. (B) Phosphoamino acid analysis of the in vitro phosphorylated p85 
band. The migration of unlabeled phosphoamino acid standards,  added 
to each acid hydrolysate, is indicated. (C) Samples were prepared as in A, 
and after the in vitro kinase reactions,  the protein comple~es were dis- 
rupted with 1.0% SDS at 100~  The samples were diluted to a final con- 
ceutration of 0.1%  SDS, and Fyn was reprecipitated with anti-Fyn an- 
tiserum and protein A-Sepharose. The autophosphoryhted, 321Xhbeled  Fyn 
band is indicated. 
recombinant GST-p85 AAlss-T24, like endogenous p85,  com- 
plexes with T ceU-derived Fyn, and undergoes IL-2-depen- 
dent tyrosine phosphorylation. 
Fyn Enhances  PI3-kinase  Activation.  The observations de- 
scribed above prompted us to examine the effect of overex- 
pression of wild-type Fyn on both basal and IL-2-inducible 
PI3-kinase activities in CTLL-2 cells. Because Fyn and Lck 
may  subserve  overlapping  functions  in  the  regulation  of 
PI3-kinase  in IL-2-stimulated T  cells (11, 26),  we used  a 
previously  described  variant  (CTLL.lck-)  of the CTLL-2 
cell line lacking Lck (11). These cells were transfected with 
an epitope-tagged Fyn expression vector and cloned by lim- 
king  dilution.  Four  Fyn-KT3-expressing  cell  lines  were 
identified by screening for tyrosine kinase activity precipitable 
with the KT3 mAh. As controls, four cell lines that did not 
express Fyn-KT3 were used.  These included the parental 
CTLL.lck- cell line, a bulk population of CTLL.lck- cells 
transfected with empty vector, and two clones (transfected 
with the Fyn-KT3 expression vector)  that did not express 
any detectable Fyn-KT3 kinase activity. To examine the overall 
level of Fyn expression in these cell lines, tom Fyn autophos- 
phorylating activity was assessed  in anti-Fyn immunoprecipi- 
tates (Fig. 4 A). The clones 9,  11, 17, and 23 all exhibited 
elevated levels of total Fyn kinase activity.  As can be seen, 
the epitope-tagged  Fyn displayed a slightly retarded migra- 
tion in the polyacrylamide  gel due to the addition of the 
peptide tag. 
CTLL-2 cell subclones expressing normal or elevated levels 
of wild-type Fyn were subsequently  assayed for anti-Ptyr- 
precipitable PI3-kinase activity. The cells were deprived of 
growth factor for 12 h, and equivalent amounts of detergent- 
soluble protein were immunoprecipitated with an anti-Ptyr 
mAb. As shown in Fig. 4, B and C, the ceU lines overex- 
pressing wild-type Fyn consistently displayed elevated basal 
and IL-2-inducible levels of PI3-kinase activities. Unexpect- 
edly, the most dramatic alteration induced by wild-type Fyn 
overexpression was the 2.5- to 3-fold increase in immunopre- 
dpitable PI3-kimse activities  observed  in IL-2-deprived CTLL- 
2 cells. This effect appeared specific for Fyn, as overexpres- 
sion of either wild-type Lck (our unpublished data,  26) or 
Src (our unpublished data) failed to increase the level of anti- 
pTyr-precipitable PI3-kinase  activities. 
The SH3 Domain of  Fyn Complexes  with T Cell-derived  PI3- 
kinasg  Previous studies suggested a physical association be- 
tween Fyn and PI3-kinase in IL-2-responsive  T  ceils (13). 
Therefore,  we analyzed the capabilities of isolated Fyn do- 
mains to mediate this interaction in vitro.  GST-fusion pro- 
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Figure  4.  PI3-kinase activities in CTLI.,2 cells expressing  wild-type Fyn. 
(A) Analysis of epitolx'-tagged  Fyn-KT3 expressing in transfected cells. 
Lysates from the indicated exponentially growing cell lines were immuno- 
precipitated with an anti-Fyn antiserum, and the immunoprecipitates were 
subjected to immune complex kinase reactions. The migration positions 
of epitope-tagged  and endogenous  Fyn are indicated. Total radioactivity 
in both bands was quantitated  during a 30-rain data acquisition period. 
The increased level of endogenous  Fyn activity evident in the "Fyn"24 
clone was not observed in repeat experiments.  (B) IL-2-deprived CTLb2 
cells either not expressing 0ck-, lck-.REP3, "Fyn"14, and "Fyn'24) or 
expressing Fyn-KT3 0nyn.9, Fyn.I1, Fyn.17, and Fyn.23) were stimulated 
for 15 min with IL-2. Cell lysates were precipitated with an anti-Ptyr mAb, 
and precipitated PI3-kinase activities were determined.  The migration of 
the phosphatidylinositol-4-phosphate  standard is indicated. Radioactivity 
in each spot was quantitated  (see below B, labeled Net counts)  and the 
data shown are net counts detected in a 180-min detection  period.  (C) 
Graphical summary of the data presented in Panel B. The means (~- SD) 
of the four data points from the Fyn-KT3-negative cells and the Fyn- 
KT3-positive cells are shown. A Student's t test analysis  of the data demon- 
strated a statistically significant enhancement  of PI3-kinase activities for 
Fyn-KT3-positive  cells compared with Fyn-KT3-negative cells in both 
IL-2-deprived (p <  0.05)  and IL,2-stimulated  (p <  0.01) samples. 
teins were expressed in E. coli  from pGEX vectors containing 
inframe insertions  of the coding sequences for either the 
NH2  terminus  through  the  SH2  domains  (amino  acids 
25-265),  NH2 terminus alone (amino acids 1-85),  SH3 do- 
main alone (amino acids 84-141), or SH2 domain alone (amino 
acids 142-265)  of Fyn (Fig. 5 A).  In addition, the coding 
sequences for the NH2 terminus through the SH3 domain 
B 
'  ]  []  -,'--~ 
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o 
I, 
0 
GST  NH  SH3  SH2  NH  NH 
SH3  SH3 
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Figure  5.  PI3-1dn~ activities binding to Src-family-derived  fusion pro- 
reins. (A) Schematic diagram  of GST-Fyn and GST-Lck fusion proteins 
used for the study. (B) II.,2-deprived CTLL-2 cells were stimulated or not 
with IL-2, and cell lysates were incubated with the indicated fusion pro- 
reins bound to GSH agerose. Fusion protein-bound  PI3-kinase activities 
were assayed  as described in Materials and Methods.  Qualitatively similar 
results have been observed in three  separate experiments. 
of I.ck (amino acids 5-295) were also inserted into the pGEX 
vector. To assess the binding of endogenous PI3-kinase  to 
the purified GST-fusion proteins, CTLL-2 cells were deprived 
of growth factor and either restimulated with medium alone 
or IL-2. Cell lysates were incubated with GSH-agarose-im- 
mobilized fusion proteins, and the resulting precipitates were 
assayed for PI3-kinase activities  (Fig. 5 B).  A low level of 
PI3-kinase activity was consistently precipitated by GST alone. 
The NH2 terminus of Fyn did not bind PI3-kinase activity 
above the GST background. In contrast, both the isolated 
Fyn SH3 and SH2 domains complexed significant levels of 
PI3-kinase activity from CTLL-2 cell lysates, and a fusion 
protein containing both  the  Fyn SH2  and SH3  domains 
reproducibly bound the highest levels of PI3-kinase activity 
in these experiments.  A fusion protein containing the NH2 
terminus, the $H3, and SH2 domains ofLck complexed much 
less CTLL-2 ceU -derived  PI3-kinase activity than did the anal- 
ogous Fyn GST-fusion protein, suggesting that active PI3- 
kinase preferentially interacts  with Fyn in this system. 
The SH3 Domain of Fyn Binds Directly to the p85 Subunit 
1804  ll~2-induced  Phosphatidylinositol  3-kinase  Activation Figure 6.  The p85 subunit  of  Pl3-kinase  binds  directly  to the SH3 do- 
main  of  l~ra. (A) GST-  or GST-I~n  fusion  protein-coupled  Sepharose  beads 
were incubated  with lysis  buffer  only  (-), or with lysates  prepared  from 
exponentially-growing  CTLL-2 cells (+). The protein complexes  were 
washed  and fractionated  by SDS-PAGE  (10% gel). The gel proteins  were 
transfered  to Immobilon  P and probed  with an anti-GST-p85  antiserum 
that had been  depleted  of  GST-reactive  antibodies.  The cell  lysat~derived, 
anti-p85-immunoreactive  band  is indicated.  (B) Parallel  binding  reactions 
were  assayed  for GST fusion  protein-bound  PD-kinase  activiti~.  The migra- 
tion of the phosphatidylinositol-4-phosphate  standard is indicated.  The 
data below  B indicate  net counts  detected  during a 60-min  data acquisi- 
tion period. (C) The GST- and GST-Fyn-coupled  Sepharose  beads were 
incubated  with GST-p85~l-~. The precipitates  were  fractionated  by SDS- 
PAGE, and immunoblotted  with anti-GST-p85  antiserum  as in A. Purified 
GST-p85 was loaded  in the far right-hand  hne (-). The full  length  GST- 
p85-immunoreactive  band is indicated. 
of  PI3-kinas~  Subsequent studies were performed to deter- 
mine whether the levels of PI3-kinase activities precipitated 
by the GST-Fyn fusion proteins reflected the amounts of p85 
in these precipitates.  To this end, lysates from exponentially 
growing CTLL-2 cells were incubated with the indicated GST- 
Fyn fusion proteins coupled covalently to Sepharose. Two par- 
allel binding reactions were performed. After binding and 
washing, one set of precipitates was eluted with SDS-PAGE 
sample buffer. Proteins were resolved by SDS-PAGE and im- 
munoblotted with an anti-p85 serum (Fig. 6 A). PI3-kinase 
enzymatic assays were performed on the parallel set of precipi- 
tates  (Fig.  6 B).  The results indicated that the binding of 
immunoreactive p85 was well correlated with the total PI3- 
kinase activity precipitated by the isolated Fyn domains. 
The interaction of cell-derived  PI3-kinase with the SH3 
domain of Fyn could occur through the  regulatory p85 
subunit, the catalytic p110 subunit, or via another adaptor 
protein present in the cell lysates. Previous work demonstrated 
that SH3 domains bind to a proline-rich consensus sequence 
(27,  28),  and examination of the p85 primary amino acid 
sequence revealed two potential SH3 domain binding sites. 
Therefore, we reasoned that p85 might interact directly with 
the Fyn SH3 domain. To assess this possibility,  the indicated 
GST-Fyn fusion proteins coupled covalently to Sepharose were 
incubated with soluble GST-p85  AAlss-Tz4. The protein preci- 
pitates were fractionated by SDS-PAGE and immunoblotted 
with an anti-p85 antiserum (Fig. 6 C). The isolated Fyn SH3 
domain also displayed the highest level of p85-binding ac- 
tivity, although the isolated Fyn SH2 domain also displayed 
detectable binding activity.  As predicted, the fusion protein 
containing both the SH2 and SH3 domains of Fyn displayed 
substantial  binding to p85. The production of GST-p85 in 
E. coli  yielded both full-length protein and a series of partial 
degradation products. Because these truncated fusion pro- 
teins bind to GSH-agarose, they most likely represent COOH- 
terminal deletions of p85, which would retain the putative 
SH3-binding sequences. Consequently, truncated GST-p85 
proteins also complexed with the GST-Fyn fusion proteins. 
Thus, the interaction between purified, recombinant p85 and 
the Fyn SH3 domain recapitulates  that observed with PI3- 
kinase derived from cell lysates (compare Fig. 6, A  and C). 
Discussion 
A growing number of hematopoietic cell surface receptors 
appear to function through PTK-dependent signal transduc- 
tion cascades (reviewed in 29). These include the coreceptors, 
CD4 and CD8; the multichain immune  recognition  receptors, 
such as the T cell antigen receptor, the B cell antigen receptor, 
and the F~ receptor; and, finally, members of the cytokine 
receptor subfamily, which includes the IL-2K. Ligation of 
these receptors characteristically  regulates the catalytic activities 
of one or more nonreceptor PTKs expressed in the host cell. 
For example, CD4 and CD8 are physically associated with 
Lck (30), whereas the T cell antigen receptor complexes  with 
Fyn (31) and ZAP70 (32).  In addition, the IL-2R interacts 
noncovalently with the Src-family kinaseg Fyn and I.ck (8-10). 
However, the molecular mechanisms coupling these receptor- 
activated kinases to downstream signal-transducing  molecules 
remain obscure. 
Both Fyn and Lck undergo catalytic activation in response 
to IL-2R stimulation. Moreover, elegant studies have demon- 
strated that both the acidic and serine-rich  domains of the 
IL-2K p70 subunit are required for the binding and IL-2-de- 
pendent activation of Lck (9).  However, Lck is clearly not 
obligatory for IL-2-induced mitogenesis, as evidenced by the 
description of a I.ck-deficient CTLL-2 cell line that remains 
fully dependent upon IL-2 for growth (11). Thus, these results 
indicate that, although Lck may be an important intracel- 
lular mediator of the IL-2R signal transduction cascade, other 
Src-family kinases expressed in T cells may serve nearly redun- 
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line, the only other highly expressed Src-family kinase is Fyn 
(11). Because Fyn has been demonstrated to complex with 
PD-kinase in T cells (13), we therefore have focused on the 
potential regulatory role of the Fyn-PI3-kinase interaction 
in IL-2-responsive  T  cells. 
Studies of a variety of growth factor receptor tyrosine ki- 
nases expressed by different cell types have identified two al- 
ternative, although not mutually exclusive, mechanisms for 
the receptor-dependent  activation of PI3-kinase. According 
to one model, receptor-mediated p85 phosphorylation modu- 
htes PI3-kinase subcellular localization or catalytic activity. 
The second model proposes  that association with the au- 
tophosphoryhted receptor itself or other tyrosine-phosphory- 
lated substrates activates PI3-kinase activity in the absence 
of detectable p85 phosphorylation (33). In some experimental 
systems, phosphorylation of p85 is observed only when the 
receptors are expressed well above physiological levels (33). 
Previous studies using a non-T cell line demonstrated that 
IL-2 mediated the tyrosine phosphorylation of p85 (34). In 
the present  report,  we have used  a cytotoxic T  cell line, 
CTLL-2, that expresses physiological numbers of functional 
IL-2Ks, and is wholly dependent upon IL-2 for mitogenesis. 
In these cells, IL-2 elicited an increase in the tyrosine phos- 
phorylation of the p85 subunit of PI3-kinase. To define fur- 
ther the mechanisms of IL-2-induced p85 phosphorylation, 
we analyzed the ability of a recombinant GST-p85  fusion 
protein to complex with and function as a substrate  for a 
CTLL-2 call-derived, IL-2-inducible tyrosine kinase. The in 
vitro assay indirectly implicated Fyn as a bona fide p85 ki- 
nase in T  cells. 
To further investigate the role of Fyn in the regulation of 
PI3-kinase activity in CTLL-2 cells, wild-type Fyn was over- 
expressed in a I.ck-deficient CTLL-2 cell line. Fyn overex- 
pression dearly increased the levels of PI3-kinase activity im- 
munoprecipitated from IL-2-deprived cells with an anti-Ptyr 
mAb, with less significant effects on the incremental increase 
in antibody-bound PI3-kinase activity induced by IL-2. The 
latter results suggest that the level of Fyn PTK activity in 
untransfected  CTLL.lck- cells may not limit the response 
of these cdls to IL-2. Alternatively, an intriguing possibility, 
which is currently under investigation  in our laboratory,  is 
that Fyn overexpression decreases the rate at which exponen- 
tially growing CTLL-2 cells enter quiescence (Go- or G1- 
phase). A Fyn-dependent alteration in the kinetics of cell cycle 
withdrawal during IL-2 deprivation might lead to a persis- 
tent  increase in  the  levd  of PI3-kinase  activity in  Fyn- 
overexpressing, IL-2-dependent T cells. Nonethdess, the en- 
hancing effect of Fyn overexpression on PI3-kinase activity, 
coupled with the demonstration of a direct interaction of p85 
with Fyn, strongly implicates Fyn as an IL-2R-linked PTK 
that phosphorylates  the downstream signal-transducing  en- 
zyme, PI3-kinase, in response to IL-2tL occupancy. These con- 
clusions do not imply that Fyn is the only PTK capable of 
regulating PI3-kinase activity in response to IL-2. Indeed, 
a recent report by Taichman et al. (26) indicated that PI3- 
kinase also associates with Lck in CTLL-2 calls; although 
previous studies from our laboratory failed to document the 
recovery of PI3-kinase in anti-Lck immunoprecipitates (13). 
Also, we have been unable to recover specifically  bound lysate~ 
derived Lck from GST-p85 fusion protein precipitates. These 
results indicate that, in this experimental system, Fyn is the 
predominant Sre-family kinase to which the IL-2R and PI3- 
kinase are coupled.  These discrepant findings might be ex- 
plained by interhboratory diffetmaces  in the CTLL-2 cell lines 
or the polydonal anti-Lck antibodies used to prepare the im- 
munoprecipitates. However, earlier results dearly indicate that 
the IL-2R is capable of coupling to both I.ck and Fyn, and 
it is plansible that both Irl'Ks subserve redundant functions 
in the activation  of PI3-kinase in response to IL-2. 
While these results were prepared for publication, reports 
describing the interaction of potential downstream effector 
substrates with several different regions of the Src-family ki- 
nases were published. The results of Pleiman et al. (35) demon- 
strated  that Ras-GTPase activating  protein, phospholipase 
C-3'2,  and MAP kinase  associate with the unique NHz- 
termini of Lyn, Fyn, and Blk. In addition, the SH3 domains 
of both Fyn and Lyn were found to associate  with cell-derived 
PI3-kinase  activity (35).  Similar  findings  have  also been 
reported for the SH3 domain of v-Src in a fibroblast model 
system (36). Our findings confirm these data, and moreover, 
strongly suggest that an SH3 domain-mediated interaction 
of Fyn with PI3-kinase functions in the regulation of PI3- 
kinase activity in IL-2-responsive  T  cells. 
Taken in aggregate,  these data allow the formulation of 
a working model for IL-2R-mediated activation of PI3-kinase. 
The SH3 and, possibly, the SH2 domains of Fyn bind con- 
stitutively and directly to the p85 subunit of PI3-kinase. IL- 
2R occupancy provokes the activation of Fyn, and, in turn, 
the phosphorylation of the Fyn-bound p85 subunit of PI3- 
kinase. This model predicts that the SH3 domains of the Src- 
family kinases may play central roles in the approximation 
of specific substrates to the catalytic domains of these PTKs. 
In support of this model, the SH3 domain of v-Src has been 
reported to bind a lllYkD protein in v-Src-transformed cells. 
Deletion of the SH3 domain prevents both the binding and 
tyrosine phosphorylation of this protein (37). 
The SH3 domains of the Src-family kinases may also par- 
ticipate in intramolecular regulation of the catalytic activi- 
ties in these enzymes. The prototypical member of this family, 
Src, is proposed to fold into an enzymatically repressed con- 
formation. This repression requires both a phosphotyrosine 
(Y527)-SH2 domain interaction as well as an intact SH3 do- 
main (38). Folding into the repressed conformation may ster- 
ically hinder the binding of p85 to the PTK, thereby ren- 
dering the kinase unable to interact with and phosphorylate 
this potential substrate. Alternatively, the interaction of other 
proteins with the SH3 domain of Src-family kinases may ab- 
rogate this repressive mechanism, thereby promoting the tran- 
sition to an active conformation. One function of PI3-kinase 
interaction with Fyn may be to supply a population of par- 
tiaUy activated Fyn molecules that would have a heightened 
sensitivity  to IL-2R-dependent activation  signals. 
SH3 domains are rapidly emerging as important motifs 
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molecular signaling  complexes. A  prototypical example of 
an SH3 domain-dependent regulatory cascade is provided by 
the recently reported association between the adaptor pro- 
rein, GRB2, and the guanine nucleotide exchange factor, SOS 
(27). This association defines a molecular link between the 
growth factor tyrosine kinase receptors and a key compo- 
nent  of the  mitogenic  signaling  pathway,  Ras.  The  data 
presented here expand upon the potential roles for the SH3 
domains of Src-family kinases.  In this context,  the ligand- 
binding specificities  of the SH3 domains may be a primary 
determinant  of the spectrum of downstream effector mole- 
cuhs that  undergo  receptor-mediated  tyrosine phosphory- 
lation. 
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